Alnylam’s Amvuttra To Take Off From Onpattro’s Runway

Most Onpattro Patients Expected To Switch

 
• By Alaric DeArment
  
Alnylam's Amvuttra won FDA approval on 13 June for hATTR-PN • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip